Attention and executive functions in children with epilepsy: what, why, and what to do

William S MacAllister1, Marsha Vasserman, Joshua Rosenthal

  • 1a Comprehensive Epilepsy Center, New York University , New York , New York.

Insights

Children with epilepsy often experience attention and executive function deficits. This review covers their neurological basis, impact in childhood epilepsy, and treatment strategies.

Area of Science:

  • Neuroscience
  • Pediatric Neurology
  • Cognitive Psychology

Background:

  • Attention and executive functions are crucial cognitive skills frequently impaired in pediatric neurological conditions.
  • Epilepsy syndromes in childhood are consistently associated with executive dysfunction.
  • Understanding these deficits is vital for effective management.

Purpose of the Study:

  • To review the current knowledge on attention and executive functions, including their neurological underpinnings.
  • To discuss general cognitive function and specific attention/executive function impairments in childhood epilepsy.
  • To explore treatment considerations and future research directions for these deficits.

Main Methods:

  • Literature review and synthesis of existing research.
  • Focus on neurological basis of attention and executive functions.
  • Analysis of cognitive function in childhood epilepsy.

Main Results:

  • Attention and executive function deficits are common in childhood neurological disorders, particularly epilepsy.
  • Specific patterns of executive dysfunction are observed across childhood epilepsy syndromes.
  • Neurological underpinnings of these cognitive skills are complex and varied.

Conclusions:

  • Children with epilepsy frequently exhibit attention and executive function impairments.
  • Targeted interventions are necessary to address these cognitive deficits.
  • Further research is needed to optimize treatment and improve outcomes for affected children.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
47
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
42
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K